Unless you’ve been living under a rock, you know that weight-loss drugs are the talk of the town. GLP-1 drugs, in particular, ...

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

Novo Nordisk shares have plunged 20% amid the disappointing trial result of its latest weight-loss drug CagriSema. The fall ...

Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Lilly investors got the jitters, saw better opportunities elsewhere, or decided to hold onto their chips. In the third ...

Eli Lilly's Zepbound has become the first drug to be FDA-approved for obstructive sleep apnoea (OSA), a sleep-related ...

Novo Nordisk and Eli Lilly are currently a duopoly in the obesity market, which reached a value of $24 billion last year ...

An 81-year-old pedestrian was transported to the hospital in serious condition after being struck by an auotmobile near the intersection of Rycroft and Ahana streets at 7 p.m. Friday. No further ...

The Sooners' regular season ended with a thud, a 37-17 loss to LSU at Tiger Stadium. OU finished 6-6 overall and 2-6 in the SEC and now awaits its bowl fate. LSU quarterback Garrett Nussmeier had been ...